PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
6.81%
Positive growth while ORCL shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-11.94%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-17.56%
Margin decline while ORCL shows 0.00% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Similar other expenses growth to ORCL's 100.00%. Walter Schloss would investigate industry patterns.
122.18%
Operating expenses growth 1.1-1.25x ORCL's 100.00%. Bill Ackman would demand justification.
129.54%
Total costs growth 1.25-1.5x ORCL's 100.00%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
123.13%
EBITDA growth 50-75% of ORCL's 171.72%. Martin Whitman would scrutinize operations.
120.70%
EBITDA margin growth 50-75% of ORCL's 188.27%. Martin Whitman would scrutinize operations.
120.35%
Operating income growth 50-75% of ORCL's 171.72%. Martin Whitman would scrutinize operations.
119.05%
Operating margin growth 50-75% of ORCL's 188.27%. Martin Whitman would scrutinize operations.
-98.97%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
EPS change of 100.00% while ORCL is flat. Bruce Berkowitz would examine quality.
100.00%
Diluted EPS change of 100.00% while ORCL is flat. Bruce Berkowitz would examine quality.
0.75%
Share count change of 0.75% while ORCL is stable. Bruce Berkowitz would verify approach.
0.75%
Diluted share change of 0.75% while ORCL is stable. Bruce Berkowitz would verify approach.